نتایج جستجو برای: cd5

تعداد نتایج: 2048  

Journal: :Journal of immunology 2001
J M Vilà J Calvo L Places O Padilla M Arman I Gimferrer C Aussel J Vives F Lozano

CD5 is a transmembrane coreceptor that modulates activation and differentiation signals mediated by the Ag-specific receptor present on both T and B1a lymphocytes. CD5 lacks intrinsic catalytic activity, and its immunomodulatory properties result from intracellular interactions mediated by the CD5 cytoplasmic tail. The nature of these interactions is currently a matter of investigation. Here, w...

Journal: :Journal of immunology 2002
Xianghuai Lu Robert C Axtell James F Collawn Andrew Gibson Louis B Justement Chander Raman

CD5 is a key regulator of Ag receptor-mediated activation, selection, and differentiation in both T and B cells. Accumulating evidence indicates that lymphocyte activation and selection are sensitive to variations in levels of CD5 on the cell surface. We now show that CD5 expression on the surface of B and T cells is regulated posttranslationally by direct interaction with the mu(2) subunit of ...

2017
Claudia M Tellez Freitas Garrett J Hamblin Carlee M Raymond K Scott Weber

The adaptive immune response is orchestrated by T helper cells and their function is dependent upon interactions between the T cell receptor (TCR), peptide MHC (pMHC) and co-receptors. TCR-pMHC interactions initiate calcium signaling cascades which determine T cell activation, survival, proliferation and differentiation. CD5 is a co-receptor that plays an important role in regulating T cell sig...

Journal: :Blood 2002
Hélène Gary-Gouy Julie Harriague Georges Bismuth Cornelia Platzer Christian Schmitt Ali H Dalloul

CD5 is a negative regulator of B-cell receptor (BCR) signaling that is up-regulated after BCR stimulation and likely contributes to B-cell tolerance in vivo. However, CD5 is constitutively expressed on the B-1 subset of B cells. Contrary to CD5(-) B-2 B cells, B-1 B cells are long-lived because of autocrine interleukin-10 (IL-10) production through unknown mechanisms. We demonstrate herein a di...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2004
Yang Yang Christopher H Contag Dean Felsher Catherine M Shachaf Yuan Cao Leonard A Herzenberg Leonore A Herzenberg James W Tung

The expression of CD5 increases progressively as thymocytes mature. We have shown that CD5 expression is controlled by a tissue-specific regulatory promoter located upstream of the CD5 translation start sites. Deletion of this regulatory promoter, which contains three potential transcription factor binding sites (CCAAT, kappa E2, and ets) reduces the promoter activity to basal level. Of these s...

Journal: :Blood 1990
S B Wormsley S M Baird N Gadol K R Rai R E Sobol

Previous studies have indicated that chronic lymphocytic leukemias (CLL) are characterized by the coexpression of CD5 and B-cell antigens, while hairy cell leukemias (HCL) typically express CD11c+CD5- B-cell immunophenotypes. In this report we describe the features of B-cell leukemias with CD11c+CD5+ immunophenotypes and the identification of novel circulating B-cell subsets defined by the expr...

2008
L. Baseggio F. Petinataud E. Callet-Bauchu A. Traverse-Glehen F. Berger C. Thieblemont J. Magaud G. Salles P. Felman B. Streubel B. Petit S. Le Gouill N. Martin-Garcia C. Copie-Bergman F. Gaillard A. Baglin J. Briere G. Roncador C. Haioun M. Delfau-Larue A. Chott P. Gaulard

Splenic marginal zone B-cell lymphoma (SMZL) is an indolent lymphoma showing some characteristic cyto-histological, cytogenetical and molecular features. Phenotypically it is defined by a negative profile with no CD5, CD10, CD23, CD43 expression. A CD5 positivity has been reported in some typical MZL cases and proposed as a marker for a more aggressive and disseminated disease. The differential...

2010
Joonyong Noh Wahn Soo Choi Geunwoong Noh Jae Ho Lee

Foxp3 is a transcript factor for regulatory T cell development. Interestingly, Foxp3-expressing cells were identified in B cells, especially in CD19(+)CD5(+) B cells, while those were not examined in CD19(+)CD5(-) B cells. Foxp3-expressing CD5(+) B cells in this study were identified in human PBMCs and were found to consist of 8.5±3.5% of CD19(+)CD5(+) B cells. CD19(+)CD5(+)Foxp3(+) B cells sho...

Journal: :The Journal of clinical investigation 1997
M Fischer U Klein R Küppers

B cells expressing the CD5 cell surface antigen are involved in certain B cell malignancies and autoimmune diseases. From studies in the mouse, it emerged that CD5+ B cells represent a separate lineage of B lymphocytes that, in contrast to conventional (CD5-) B cells, are not driven into T cell-dependent immune responses in which rearranged variable (V) region genes are diversified by somatic h...

Journal: :Journal of immunology 2007
Hélène Gary-Gouy Alexander Sainz-Perez Jean-Brice Marteau Anne Marfaing-Koka Jozo Delic Hélène Merle-Beral Pierre Galanaud Ali Dalloul

Chronic lymphocytic leukemia (CLL) results in the accumulation of B cells, presumably reflecting the selection of malignant cell precursors with Ag combined with complex alterations in protein activity. Repeated BCR stimulation of normal B cells leads to anergy and CD5 expression, both of which are features of CLL. Because CD5 is phosphorylated on tyrosine following BCR engagement and negativel...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید